Crafting a Path to Success in rAAV-Based Gene Therapy Development

Approaches for Addressing rAAV Immunotoxicity and Overcoming GMP Manufacturing Challenges

16

November

  • 3PM London / 10AM New York
  • Free

Why attend?

Speakers

Select a speaker to learn more

Back
Dr Irene Ferreira
Head of CGT Platform Innovation & Management at Revvity Gene Delivery
Next speaker
Back
Mathias Kahl
Head of Process Development at IDT Biologika
Next speaker

Enquiry